Search Results - "Shiomi, Hiroki Shiomi"

Paradigm Shift in Ischemia Evaluation and Accumulating Evidence of Safety of Deferred Coronary Revascularization on the Basis of Invasive Fractional Flow Reserve Measurement by Shiomi, Hiroki

Get full text

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial by Park, Seung-Jung, Ahn, Jung-Min, Kang, Do-Yoon, Yun, Sung-Cheol, Ahn, Young-Keun, Kim, Won-Jang, Nam, Chang-Wook, Jeong, Jin-Ok, Chae, In-Ho, Shiomi, Hiroki, Kao, Hsien-Li, Hahn, Joo-Yong, Her, Sung-Ho, Lee, Bong-Ki, Ahn, Tae Hoon, Chang, Ki-Yuk, Chae, Jei Keon, Smyth, David, Mintz, Gary S, Stone, Gregg W, Park, Duk-Woo, Park, Seung-Jung, Ahn, Jung-Min, Kang, Do-Yoon, Yun, Sung-Cheol, Ahn, Young-Keun, Kim, Won-Jang, Nam, Chang-Wook Nam, Jeong, Jin-Ok, Chae, In-Ho, Shiomi, Hiroki Shiomi, Kao, Hsien-Li, Hahn, Joo-Yong, Her, Sung-Ho, Lee, Bong-Ki, Ahn, Tae Hoon, Chang, Ki-Yuk, Chae, Jei-Keon, Smyth, David, Mintz, Gary, Stone, Gregg, Park, Duk-Woo

“…Acute coronary syndrome and sudden cardiac death are often caused by rupture and thrombosis of lipid-rich atherosclerotic coronary plaques (known as vulnerable…”
Get full text

Cancer-Associated Venous Thromboembolism in the Real World　― From the COMMAND VTE Registry by Sakamoto, Jiro, Yamashita, Yugo, Morimoto, Takeshi, Amano, Hidewo, Takase, Toru, Hiramori, Seiichi, Kim, Kitae, Oi, Maki, Akao, Masaharu, Kobayashi, Yohei, Toyofuku, Mamoru, Izumi, Toshiaki, Tada, Tomohisa, Chen, Po-Min, Murata, Koichiro, Tsuyuki, Yoshiaki, Saga, Syunsuke, Nishimoto, Yuji, Sasa, Tomoki, Kinoshita, Minako, Togi, Kiyonori, Mabuchi, Hiroshi, Takabayashi, Kensuke, Yoshikawa, Yusuke, Shiomi, Hiroki, Kato, Takao, Makiyama, Takeru, Ono, Koh, Tamura, Toshihiro, Nakagawa, Yoshihisa, Kimura, Takeshi, on behalf of the COMMAND VTE Registry Investigators

“…Background:There is a paucity of data on the management and prognosis of cancer-associated venous thromboembolism (VTE), leading to uncertainty about optimal…”
Get full text

Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　― From the CREDO-Kyoto Registry Cohort-3 by Natsuaki, Masahiro, Morimoto, Takeshi, Shiomi, Hiroki, Ehara, Natsuhiko, Taniguchi, Ryoji, Tamura, Toshihiro, Tada, Takeshi, Suwa, Satoru, Kaneda, Kazuhisa, Watanabe, Hirotoshi, Tazaki, Junichi, Watanabe, Shin, Yamamoto, Erika, Saito, Naritatsu, Fuki, Masayuki, Takeda, Teruki, Eizawa, Hiroshi, Shinoda, Eiji, Mabuchi, Hiroshi, Shirotani, Manabu, Uegaito, Takashi, Matsuda, Mitsuo, Takahashi, Mamoru, Inoko, Moriaki, Tamura, Takashi, Ishii, Kazuhisa, Onodera, Tomoya, Sakamoto, Hiroki, Aoyama, Takeshi, Sato, Yukihito, Ando, Kenji, Furukawa, Yutaka, Nakagawa, Yoshihisa, Kadota, Kazushige, Kimura, Takeshi, on behalf of the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators

“…Background:The prevalence of and expected bleeding event rate in patients with the Japanese version of high bleeding risk (J-HBR) criteria are currently…”
Get full text

Anticoagulation Therapy for Venous Thromboembolism in the Real World　― From the COMMAND VTE Registry by Yamashita, Yugo, Morimoto, Takeshi, Amano, Hidewo, Takase, Toru, Hiramori, Seiichi, Kim, Kitae, Konishi, Takashi, Akao, Masaharu, Kobayashi, Yohei, Inoue, Takeshi, Oi, Maki, Izumi, Toshiaki, Takahashi, Kotaro, Tada, Tomohisa, Chen, Po-Min, Murata, Koichiro, Tsuyuki, Yoshiaki, Sakai, Hiroshi, Saga, Syunsuke, Sasa, Tomoki, Sakamoto, Jiro, Yamada, Chinatsu, Kinoshita, Minako, Togi, Kiyonori, Ikeda, Tomoyuki, Ishii, Katsuhisa, Kaneda, Kazuhisa, Mabuchi, Hiroshi, Otani, Hideo, Takabayashi, Kensuke, Takahashi, Mamoru, Shiomi, Hiroki, Makiyama, Takeru, Ono, Koh, Kimura, Takeshi, on behalf of COMMAND VTE Registry Investigators

“…Background:Venous thromboembolism (VTE) has a long-term risk of recurrence, which can be prevented by anticoagulation therapy.Methods and Results:The COMMAND…”
Get full text

Response by Yamamoto et al to Letter Regarding Article, “Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention” by Yamamoto, Ko, Shiomi, Hiroki, Morimoto, Takeshi, Kimura, Takeshi

Get full text

Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention by Natsuaki, Masahiro, Morimoto, Takeshi, Shiomi, Hiroki, Yamaji, Kyohei, Watanabe, Hirotoshi, Shizuta, Satoshi, Kato, Takao, Ando, Kenji, Nakagawa, Yoshihisa, Furukawa, Yutaka, Tada, Tomohisa, Nagao, Kazuya, Kadota, Kazushige, Toyofuku, Mamoru, Kimura, Takeshi

“…BACKGROUND:Recently, the Academic Research Consortium for High Bleeding Risk (ARC-HBR) has been proposed to standardize the definition of HBR, which was…”
Get full text

Prognostic Value and Risk Continuum of Noninvasive Fractional Flow Reserve Derived from Coronary CT Angiography by Ihdayhid, Abdul Rahman, Norgaard, Bjarne L, Gaur, Sara, Leipsic, Jonathan, Nerlekar, Nitesh, Osawa, Kazuhiro, Miyoshi, Toru, Jensen, Jesper M, Kimura, Takeshi, Shiomi, Hiroki, Erglis, Andrejs, Jegere, Sanda, Oldroyd, Keith G, Botker, Hans Erik, Seneviratne, Sujith K, Achenbach, Stephan, Ko, Brian S

“…Background Coronary CT angiography with noninvasive fractional flow reserve (FFR) predicts lesion-specific ischemia when compared with invasive FFR. The longer…”
Get full text

Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism　― From the COMMAND VTE Registry by Nishimoto, Yuji, Yamashita, Yugo, Kim, Kitae, Morimoto, Takeshi, Saga, Syunsuke, Amano, Hidewo, Takase, Toru, Hiramori, Seiichi, Oi, Maki, Akao, Masaharu, Kobayashi, Yohei, Toyofuku, Mamoru, Izumi, Toshiaki, Tada, Tomohisa, Chen, Po-Min, Murata, Koichiro, Tsuyuki, Yoshiaki, Sasa, Tomoki, Sakamoto, Jiro, Kinoshita, Minako, Togi, Kiyonori, Mabuchi, Hiroshi, Takabayashi, Kensuke, Yoshikawa, Yusuke, Shiomi, Hiroki, Kato, Takao, Makiyama, Takeru, Ono, Koh, Sato, Yukihito, Kimura, Takeshi, on behalf of the COMMAND VTE Registry Investigators

“…Background:Patients with cancer-associated venous thromboembolism (VTE) are at high risk for recurrent VTE and are recommended to receive prolonged…”
Get full text

Sex Differences in Clinical Outcomes After Percutaneous Coronary Intervention by Takeji, Yasuaki, Morimoto, Takeshi, Shiomi, Hiroki, Kato, Eri Toda, Imada, Kazuaki, Yoshikawa, Yusuke, Matsumura-Nakano, Yukiko, Yamamoto, Ko, Yamaji, Kyohei, Toyota, Toshiaki, Tada, Tomohisa, Tazaki, Junichi, Yamamoto, Erika, Nakatsuma, Kenji, Suwa, Satoru, Ehara, Natsuhiko, Taniguchi, Ryoji, Tamura, Toshihiro, Watanabe, Hiroki, Toyofuku, Mamoru, Yamamoto, Takashi, Shinoda, Eiji, Mabuchi, Hiroshi, Inoko, Moriaki, Onodera, Tomoya, Sakamoto, Hiroki, Inada, Tsukasa, Ando, Kenji, Furukawa, Yutaka, Sato, Yukihito, Kadota, Kazushige, Nakagawa, Yoshihisa, Kimura, Takeshi

“…Background: There is a scarcity of studies comparing the clinical outcomes after percutaneous coronary intervention (PCI) for women and men stratified by the…”
Get full text

External Validation of the SYNTAX Score II 2020 by Hara, Hironori, Shiomi, Hiroki, van Klaveren, David, Kent, David M, Steyerberg, Ewout W, Garg, Scot, Onuma, Yoshinobu, Kimura, Takeshi, Serruys, Patrick W

“…The SYNTAX score II 2020 (SSII-2020) was derived from cross correlation and externally validated in randomized trials to predict death and major adverse…”
Get full text

Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration by Toyota, Toshiaki, Shiomi, Hiroki, Morimoto, Takeshi, Natsuaki, Masahiro, Kimura, Takeshi

“…The Dual Antiplatelet Therapy (DAPT) study demonstrated that DAPT beyond 1-year after drug-eluting stent (DES) implantation, as compared with aspirin therapy…”
Get full text

Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention by Natsuaki, Masahiro, Morimoto, Takeshi, Shiomi, Hiroki, Kadota, Kazushige, Tada, Tomohisa, Takeji, Yasuaki, Matsumura-Nakano, Yukiko, Yoshikawa, Yusuke, Watanabe, Hirotoshi, Yamamoto, Ko, Imada, Kazuaki, Domei, Takenori, Yamaji, Kyohei, Kaneda, Kazuhisa, Taniguchi, Ryoji, Ehara, Natsuhiko, Nawada, Ryuzo, Toyofuku, Mamoru, Shinoda, Eiji, Suwa, Satoru, Tamura, Toshihiro, Inada, Tsukasa, Matsuda, Mitsuo, Aoyama, Takeshi, Sato, Yukihito, Furukawa, Yutaka, Ando, Kenji, Nakagawa, Yoshihisa, Kimura, Takeshi, for the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators

“…Background:Data evaluating the effects of acute coronary syndrome (ACS) relative to stable coronary artery disease (CAD) on bleeding risk after percutaneous…”
Get full text

Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies by Yoshikawa, Yusuke, Shiomi, Hiroki, Watanabe, Hirotoshi, Natsuaki, Masahiro, Kondo, Hirokazu, Tamura, Toshihiro, Nakagawa, Yoshihisa, Morimoto, Takeshi, Kimura, Takeshi

“…The dual antiplatelet therapy (DAPT) score was developed to estimate ischemic and bleeding risks from the DAPT study. However, few studies validated its…”
Get full text

Clinical Impact of Left Ventricular Outflow Tract Obstruction in Takotsubo Cardiomyopathy by Kawaji, Tetsuma, Shiomi, Hiroki, Morimoto, Takeshi, Tazaki, Junichi, Imai, Masao, Saito, Naritatsu, Makiyama, Takeru, Shizuta, Satoshi, Ono, Koh, Kimura, Takeshi

“…Background:A hyperdynamic state of the basal left ventricle sometimes results in obstruction of the left ventricular outflow tract (LVOT). However, the…”
Get full text

ST-segment elevation myocardial infarction by Vogel, Birgit, Claessen, Bimmer E., Arnold, Suzanne V., Chan, Danny, Cohen, David J., Giannitsis, Evangelos, Gibson, C. Michael, Goto, Shinya, Katus, Hugo A., Kerneis, Mathieu, Kimura, Takeshi, Kunadian, Vijay, Pinto, Duane S., Shiomi, Hiroki, Spertus, John A., Steg, P. Gabriel, Mehran, Roxana

“…ST-segment elevation myocardial infarction (STEMI) is the most acute manifestation of coronary artery disease and is associated with great morbidity and…”
Get full text

CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing by Xu, Sijia, Shiomi, Hiroki, Yamashita, Yugo, Koyama, Satoshi, Horie, Takahiro, Baba, Osamu, Kimura, Masahiro, Nakashima, Yasuhiro, Sowa, Naoya, Hasegawa, Koji, Suzuki, Ayako, Suzuki, Yutaka, Kimura, Takeshi, Ono, Koh

“…Familial hypercholesterolemia is an inherited disorder that remains underdiagnosed. Conventional genetic testing methods such as next-generation sequencing…”
Get full text

Meta-Analysis of Long-Term Clinical Outcomes of Everolimus-Eluting Stents by Toyota, Toshiaki, MD, Shiomi, Hiroki, MD, Morimoto, Takeshi, MD, MPH, Kimura, Takeshi, MD

“…The superiority of everolimus-eluting stents (EES) over sirolimus-eluting stents (SES) for long-term clinical outcomes has not been yet firmly established. We…”
Get full text

Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention by Yamamoto, Ko, Shiomi, Hiroki, Morimoto, Takeshi, Miyazawa, Akiyoshi, Watanabe, Hiroki, Nakamura, Sunao, Suwa, Satoru, Domei, Takenori, Ono, Koh, Sakamoto, Hiroki, Shigetoshi, Masataka, Taniguchi, Ryoji, Okayama, Hideki, Yokomatsu, Takafumi, Muto, Masahiro, Kawaguchi, Ren, Kishi, Koichi, Hadase, Mitsuyoshi, Fujita, Tsutomu, Nishida, Yasunori, Nishino, Masami, Otake, Hiromasa, Natsuaki, Masahiro, Watanabe, Hirotoshi, Suematsu, Nobuhiro, Tanabe, Kengo, Abe, Mitsuru, Hibi, Kiyoshi, Kadota, Kazushige, Ando, Kenji, Kimura, Takeshi, on behalf of the OPTIVUS-Complex PCI Investigators

“…Background: There is a scarcity of data evaluating contemporary real-world dual antiplatelet therapy (DAPT) strategies after percutaneous coronary intervention…”
Get full text

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores by Natsuaki, Masahiro, Morimoto, Takeshi, Yamaji, Kyohei, Watanabe, Hirotoshi, Yoshikawa, Yusuke, Shiomi, Hiroki, Nakagawa, Yoshihisa, Furukawa, Yutaka, Kadota, Kazushige, Ando, Kenji, Akasaka, Takashi, Hanaoka, Keiichi Igarashi, Kozuma, Ken, Tanabe, Kengo, Morino, Yoshihiro, Muramatsu, Toshiya, Kimura, Takeshi

“…Background Prediction of thrombotic and bleeding risk is important to optimize antithrombotic therapy after percutaneous coronary intervention. Methods and…”
Get full text